Recent Finacing
Recent Raise
OncoEthix is a Lausanne-based biotechnology company developing oncology drugs, including OTX015, an oral BET bromodomain (BRD2/3/4) inhibitor in clinical development for acute leukemia and hematologic malignancies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors